Botulinum toxin for simple motor tics: A randomized, double-blind, controlled clinical trial

Neurology

Volumn 56, Issue 5, 2001, Pages 605-610

  Marras, Connie ^a   Andrews, David ^a   Sime, Elspeth ^a   Lang, Anthony E ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b TORONTO WESTERN HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; CLONAZEPAM; CLONIDINE; METHYLPHENIDATE; NEUROLEPTIC AGENT; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISABILITY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; MALE; MUSCLE WEAKNESS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESTLESSNESS; TIC;

EID: 0035852961     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.5.605     Document Type: Article

References (13)

1. Clinical phenomenology of tic disorder: Selected aspects
2. Botulinum toxin injection into vocal cord in the treatment of malignant coprolalia associated with Tourette's syndrome
3. Vocal tics in Gilles da la Tourette syndrome treated with botulinum toxin injections
4. Botulinum toxin for refractory vocal tics
5. Perioperative use of botulinum toxin for movement disorder-induced cervical spine disease
6. Severe motor tics causing cervical myelopathy in Tourette's syndrome
7. Botulinum toxin in the treatment of dystonic tics
8. Botulinum toxin in the treatment of tics
9. A rating scales for Gilles de la Tourette's syndrome: Description, reliability and validity data
10. A new instrument for clinical studies of Tourette's syndrome
11. The Yale Global Tic Severity Scale: Initial testing of a clinician-rated scale of tic severity
12. Rating tic severity